-New Data From Immutep's Efti To Be Presented At ESMO
Aug 26, 2020 - ENP Newswire
Immutep Limited (ASX: IMM; NASDAQ: IMMP) ('Immutep' or 'the Company'), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, pleased to announce new data is scheduled to be presented in four poster presentations at the ESMO Virtual Congress 2020 which is being held from 19 to 21 September 2020, Central European Summer Time (CEST).
The new data will be presented from Immutep's phase II TACTI-002 and the investigator-initiated phase I cl...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
